Indicators

Markets:

News

Latest News about LGND

Recent news which mentions LGND

< Previous 1 2 Next >

Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's

November 28, 2023

Ligand Pharma Updates Annual Guidance As It Spins Out Pelican Subsidiary

September 19, 2023

Where Ligand Pharmaceuticals Stands With Analysts

September 19, 2023

Analyst Expectations for Ligand Pharmaceuticals's Future

August 23, 2023

Why Are Novan Shares Nosediving Today?

July 17, 2023

3 Stocks That Smart Investors Should Be Flocking to Now

May 30, 2023

Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial

May 16, 2023

Recap: Ligand Pharmaceuticals Q1 Earnings

May 04, 2023

Earnings Scheduled For February 22, 2023

February 22, 2023

Ligand Pharmaceuticals Earnings Preview

February 21, 2023

Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment

February 21, 2023

February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More

January 31, 2023

Roth Capital Maintains Buy Rating for Ligand Pharmaceuticals: Here's What You Need To Know

December 23, 2022

Tesla To $175? Here Are 10 Other Price Target Changes For Friday

December 23, 2022

Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says

December 16, 2022

Ligand Pharma Issues Mixed Guidance For FY23

December 13, 2022

Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices

December 13, 2022

These small-cap stocks might make you the most money in 2023, based on two important data points

December 07, 2022

Earnings Outlook For Ligand Pharmaceuticals

November 04, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

November 02, 2022

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

November 01, 2022

Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients

August 25, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

August 24, 2022

Ligand Pharmaceuticals: Q2 Earnings Insights

August 08, 2022

Barclays Maintains Overweight Rating for Ligand Pharmaceuticals: Here's What You Need To Know

July 05, 2022

ASCO 2022: Surprising News in Cancer Research

June 10, 2022

10 Biggest Price Target Changes For Monday

May 16, 2022

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

March 24, 2022

Ligand To Spin-Off OmniAb Via Avista Capital-Backed SPAC Merger

March 24, 2022

Stocks That Hit 52-Week Lows On Wednesday

February 23, 2022

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.